JP Morgan Maintains Neutral on Sotera Health, Raises Price Target to $18

Benzinga · 1d ago
JP Morgan analyst Casey Woodring maintains Sotera Health (NASDAQ:SHC) with a Neutral and raises the price target from $16 to $18.